IDRA Idera Pharmaceuticals Inc

Idera Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in the discovery, development and commercialization of novel therapeutics for oncology and rare diseases.

$1.02
As of 05/12/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/14/2001
Outstanding shares:  50,033,297
Average volume:  1,675,494
Market cap:   $52,034,629
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    45168K405
ISIN:        US45168K4058
Sedol:      BFNQL28
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.83
PS ratio:   0.00
Return on equity:   -286.88%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy